Clinical Trial Update: First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial registry entry indicating an ongoing study of first-line gemcitabine plus cisplatin for locally advanced breast cancer (Stage IIIC), wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: The National Center of Oncology, Azerbaijan | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING